The Journal of Experimental Medicine
StemCell Technologies
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published online 25 July 2005 doi:10.1084/jem2023iti5
Rockefeller University Press, 0022-1007 $8.00
JEM, Volume 202, Number 3, 335-335
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Van Epps, H. L.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Van Epps, H. L.
Related Collections
Right arrowRelated Article
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

IN THIS ISSUE

TIM-2 tones down Th2
The TIM (T cell immunoglobulin mucin) proteins are emerging as critical regulators of T helper (Th) cell responses and as potential susceptibility factors for the development of allergic and autoimmune diseases. On page 437, Chakravarti and colleagues add to the developing TIM story by showing that TIM-2 is preferentially expressed on differentiated Th2 cells and inhibits their expansion and function. These molecules, according to senior author Vijay Kuchroo, are not only critical modulators of the CD4+ Th cell response, but are the first reliable markers of differentiated Th cell subsets.

The TIM genes were originally identified as residents of a chromosomal locus that conferred susceptibility to asthma. Since then, this group has shown that TIM3 is expressed exclusively on polarized Th1 cells and dampens their activation. They now show an analogous function for TIM-2 on Th2 cells. Blocking TIM-2 increased the production of Th2 cytokines and protected mice against Th1-driven experimental autoimmune encephalomyelitis, suggesting that TIM-2 normally inhibits excessive activation of Th2 cells.

Although the signals in T cells that drive the expression of TIM2 and TIM3 are not known, their exclusive expression on polarized Th cells (not simply activated T cells) suggests that TIM2 and TIM3 expression may be driven by Th2- and Th1-specific transcription factors, respectively. The structure of the TIM molecules, which most closely resembles the adhesion molecule MAdCAM, suggests that these proteins may also affect lymphocyte trafficking. {JEMiti_end}



Heather L. Van Epps

hvanepps{at}rockefeller.edu


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Related Article

Tim-2 regulates T helper type 2 responses and autoimmunity
Sumone Chakravarti, Catherine A. Sabatos, Sheng Xiao, Zsolt Illes, Eugene K. Cha, Raymond A. Sobel, Xin X. Zheng, Terry B. Strom, and Vijay K. Kuchroo
J. Exp. Med. 2005 202: 437-444. [Abstract] [Full Text] [PDF]




This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Van Epps, H. L.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Van Epps, H. L.
Related Collections
Right arrowRelated Article
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS